Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer

Royal Bournemouth Hospital, Bournemouth

Bristol Haematology and Oncology Centre, Bristol

Queen's Hospital, Burton-on-Trent

Addenbrooke's Hospital, Cambridge

Gloucestershire Oncology Centre at Cheltenham General Hospital, Cheltenham

Derbyshire Royal Infirmary, Derby

Dorset County Hospital, Dorchester

Gloucestershire Royal Hospital, Gloucester

Diana Princess of Wales Hospital, Grimsby

Princess Royal Hospital at Hull and East Yorkshire NHS Trust, Hull

Ipswich Hospital, Ipswich

Leeds Cancer Centre at St. James's University Hospital, Leeds

Leicester Royal Infirmary, Leicester

Lincoln County Hospital, Lincoln

Saint Bartholomew's Hospital, London

Medical Research Council Clinical Trials Unit, London

Guy's Hospital, London

Royal Marsden - London, London

Charing Cross Hospital, London

Maidstone Hospital, Maidstone

Christie Hospital, Manchester

Clatterbridge Centre for Oncology, Merseyside

James Cook University Hospital, Middlesbrough

Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle upon Tyne

Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood

Derriford Hospital, Plymouth

Dorset Cancer Centre, Poole Dorset

Portsmouth Oncology Centre at Saint Mary's Hospital, Portsmouth Hants

Whiston Hospital, Prescot Merseyside

Berkshire Cancer Centre at Royal Berkshire Hospital, Reading

Scarborough General Hospital, Scarborough

Scunthorpe General Hospital, Scunthorpe

Cancer Research Centre at Weston Park Hospital, Sheffield

Wexham Park Hospital, Slough, Berkshire

Southampton General Hospital, Southampton

University Hospital of North Staffordshire, Stoke-on-Trent

Torbay Hospital, Torquay

Aberdeen Royal Infirmary, Aberdeen

Velindre Cancer Center at Velindre Hospital, Cardiff